Kaneka’s affiliate Spanish company AB-Biotics will feature its portfolio of patented strains with characterised mechanisms of action, premium probiotic solutions targeting specific therapeutic areas, and market-ready products.
The team will be available at stand J110 to discuss the recent clinical studies supporting the benefits and delivery format innovations.
Miquel Bonachera, co-founder and executive director of AB-Biotics, stated that the company's unique approach to product development has a lot to offer the entire category of biotics.
They will also highlight results in growing health areas, showcasing latest products in a range including MetaGuard, a probiotic blend of Levilactobacillus brevis CECT7480, and Lactoplantibacillus plantarum CECT7528 and CECT7529.
In the eye health space, AB-Protears, formatted as ophthalmic bacterial lysate presented in drop form, contains the strain Latilactobacillus sakei probio65 and is aimed at consumers suffering from dry eye disease (DED) symptoms.
Samples of familiar products will also be available at the stand, including i3.1, a three-strain probiotic blend clincally studied to modulate the gut-brain axis, fighting back against digestive disorders linked to psychological imbalances such as stress-related diarrhoea and irritable bowel syndrome.
Samples will also be available of Yogumel Defenses, a probiotic yogurt mixture including the strain L. plantarum DR7 and vitamin C. This solution delivers high-potency live bacteria to ferment milk and allows consumers to make sustainable and healthy probiotic yogurts at home, supporting the normal functioning of the immune system.
In addition to traditional formats, prototypes of capsule sachets and child-friendly aluminium tubes will be on display, which ensures probiotics in liquid form are dispensed carefully with no loss of product, all while maintaining stability.